Bionano Genomics, Inc.
BNGO
$4.08
-$0.02-0.49%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -21.85% | -11.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -21.85% | -11.38% | |||
| Cost of Revenue | 179.97% | -12.77% | |||
| Gross Profit | -426.73% | -8.46% | |||
| SG&A Expenses | -18.11% | -41.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.74% | -33.50% | |||
| Operating Income | -43.18% | 40.78% | |||
| Income Before Tax | -173.01% | 48.48% | |||
| Income Tax Expenses | -7.69% | 244.44% | |||
| Earnings from Continuing Operations | -172.72% | 48.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -172.72% | 48.37% | |||
| EBIT | -43.18% | 40.78% | |||
| EBITDA | -32.77% | 45.97% | |||
| EPS Basic | -114.62% | 59.70% | |||
| Normalized Basic EPS | 4.68% | 45.25% | |||
| EPS Diluted | -114.62% | 59.98% | |||
| Normalized Diluted EPS | 4.68% | 45.25% | |||
| Average Basic Shares Outstanding | 27.06% | 28.15% | |||
| Average Diluted Shares Outstanding | 27.06% | 28.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
